Q: Did the large group of short sellers get slaughtered this morning when TherapeuticsMD announced the sale of their company for $10/share - up 354%!
Will this provide any material benefit to Knight Therapeutics as a shareholder and as a distributor of some of TXMD's products?
Thanks.
Will this provide any material benefit to Knight Therapeutics as a shareholder and as a distributor of some of TXMD's products?
Thanks.
Q: What do you know about the pop in TherapeuticsMD's price today on big volume?
Thank you.
Thank you.
Q: Cantor just initiated coverage with a $27 price target on Therapeutics MD saying their three products are under-appreciated and sales will rise faster than expected.
What do you think and is there a short position on this stock?
Thanks.
What do you think and is there a short position on this stock?
Thanks.